Baird Medical Investment HolBDMD
13F holders, Q2 2025 (June 30)10holders +4
5new positions
1sold out
$3.39avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Baird Medical Investment Hol (BDMD) in their 13F filings, up 4 from Q1 2025. 5 opened new positions and 1 sold out. The largest holders were Highbridge Capital Management LLC ($458K), UBS Group AG ($335K) and Periscope Capital Inc. ($308K).
- Company
- Baird Medical Investment Hol
- CUSIP
- G0705H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $596K |
| Exits | 1 | $111K |
All 13F filers, Q1 2025 → Q2 2025: 206,571 shares bought and 25,828 shares sold, net +180,743 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Highbridge Capital Management LLC | 0.07% | No change | 125,000 | $458K |
| UBS Group AG | 0.00% | Add +60.6% | 91,449 | $335K |
| Periscope Capital Inc. | 0.12% | No change | 125,000 | $308K |
| Northern Trust Corp. | 0.00% | New | 52,441 | $192K |
| Susquehanna International Group, LLP | 0.00% | New | 44,666 | $164K |
| Jane Street Group, LLC | 0.00% | New | 38,844 | $142K |
| Virtu Financial LLC | 0.01% | New | 26,356 | $97K |
| Geode Capital Management, LLC | 0.00% | Add +59.7% | 25,442 | $93K |
| Morgan Stanley | 0.00% | Reduce -33.7% | 8,734 | $32K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 241 | $883 |
"% of holder's portfolio" is BDMD's weight in each manager's 13F, not the share of Baird Medical Investment Hol the manager owns.